세계의 광간섭 단층촬영(OCT) 시장 - 규모, 점유율, 성장 및 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2024-2032년)

Growth Factors of optical coherence tomography (OCT) Market

The global optical coherence tomography (OCT) market continues to grow rapidly due to rising demand for early and accurate diagnostic imaging across ophthalmology, cardiology, oncology, and neurology. According to the latest industry analysis, the market reached USD 1.33 billion in 2024, is projected to rise to USD 1.46 billion in 2025, and is expected to reach USD 3.32 billion by 2032, reflecting a strong CAGR of 12.4% during the forecast period. North America maintained its leadership, contributing 38.35% of the global market share in 2024, supported by high disease prevalence, advanced technology adoption, and growing demand for precision imaging tools.

Increasing Disease Burden Driving Market Expansion

The rising prevalence of chronic diseases is a major contributor to the increasing adoption of OCT systems. Global rates of glaucoma, diabetic retinopathy, cardiovascular disease, and cancer continue to climb, creating a strong need for early and minimally invasive diagnostic technologies. In the U.S., for example, approximately 4.22 million adults were living with glaucoma in 2022, according to JAMA Ophthalmology. OCT's ability to capture detailed cross-sectional tissue images makes it a preferred diagnostic tool, especially in ophthalmology-where the segment held the largest market share in 2024.

The growing need for accurate imaging in conditions such as age-related macular degeneration, optic neuritis, and vascular abnormalities further boosts product demand. High accuracy, rapid processing, and non-invasive workflow make OCT an essential diagnostic technology across hospitals, specialty clinics, and ambulatory surgical centers.

Market Restraints: High Costs and Alternative Technologies

Despite strong adoption, the market faces challenges due to the high cost of OCT devices. Entry-level instruments may cost around USD 8,000, while advanced flagship systems can reach USD 70,000, making affordability a major barrier in developing economies. The presence of alternative diagnostic tools-such as intravascular ultrasound (IVUS), ultrasound biomicroscopy, and intravital microscopy-also limits penetration, as these technologies offer lower-cost options for similar clinical indications.

Market Opportunities: Integration of Telemedicine and AI

One of the most promising trends shaping the future of the OCT market is the integration of telemedicine and artificial intelligence. A 2022 study by the Association for Research in Vision and Ophthalmology demonstrated that OCT-AI telemedicine platforms significantly enhanced retinal disease screening and referral accuracy. Remote diagnostics allow clinicians to interpret OCT images from anywhere, improving access to care and supporting early detection of chronic eye diseases.

Additionally, AI-based OCT systems-such as Abbott's Ultreon coronary imaging platform and Heidelberg Engineering's FDA-approved OCT angiography module-are transforming diagnosis through automation and real-time analytics. These innovations signal a shift toward more connected, intelligent, and patient-centric imaging solutions.

Key Market Trends

Several major trends are influencing market growth, including:

• Expansion of new product launches in 2024, such as ZEISS's upgraded CIRRUS 6000 OCT platform featuring enhanced cybersecurity and data-driven workflow.
• Increased adoption of spectral domain OCT (SD-OCT), which dominated 2024 due to higher resolution and faster image capture compared to traditional time-domain systems.
• Growing uptake of portable and handheld OCT devices, driven by their ease of use in outpatient settings, rural clinics, and emergency environments.
• Expanding application of OCT in cardiology, dermatology, and neurology, supported by U.S. FDA Breakthrough Device approvals.

Regional Insights

North America remained the leading region in 2024, valued at USD 0.51 billion, driven by technological advancements, high healthcare expenditure, and widespread availability of branded products. The U.S. leads the region due to strong adoption of AI-enabled systems and a rising burden of chronic ophthalmic diseases.

Asia Pacific is expected to grow at the fastest rate through 2032, supported by new product introductions such as Abbott's Ultreon 1.0 in India and expanding healthcare infrastructure.

Europe held a significant share in 2024, supported by high diabetes prevalence-affecting one in eleven people-and a strong manufacturer base including ZEISS and Heidelberg Engineering.

Latin America and the Middle East & Africa are experiencing steady expansion due to rising awareness and improving diagnostic access.

Conclusion

The optical coherence tomography market is on a strong growth trajectory, rising from USD 1.33 billion in 2024 to USD 1.46 billion in 2025, and expected to reach USD 3.32 billion by 2032. Driven by increasing disease prevalence, technological innovation, and telemedicine adoption, OCT is becoming an indispensable diagnostic solution across clinical specialties.

Segmentation By Device Type

• Tabletop
• Portable and Handheld

By Technology

• Time Domain OCT (TD-OCT)
• Spectral Domain OCT (SD-OCT)
• Swept Source OCT (SS-OCT)

By Application

• Ophthalmology
• Cardiology
• Oncology
• Others

By End-user

• Hospitals & ASCs
• Specialty Clinics
• Others

By Region

• North America (By Device Type, By Technology, By Application, By End-user, and By Country)
  • U.S.
  • Canada
• Europe (By Device Type, By Technology, By Application, By End-user, and By Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Device Type, By Technology, By Application, By End-User, and By Country/Sub-region)
  • Japan
  • China
  • Australia
  • India
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Device Type, By Technology, By Application, By End-User, and By Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Device Type, By Technology, By Application, By End-User, and By Country/Sub-region)
  • South Africa
  • GCC
• Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Chronic Diseases - by Key Countries/Sub-region, 2024
• 4.2. New Product Launches - by Key Players
• 4.3. Key Industry Development (Mergers, Acquisitions, Partnerships, etc.)
• 4.4. Impact of COVID-19 on the Market

5. Global Optical Coherence Tomography Market Analysis, Insights and Forecast, 2019-2032

• 5.1. Market Analysis, Insights and Forecast - By Device Type
  • 5.1.1. Tabletop
  • 5.1.2. Portable and Handheld
• 5.2. Market Analysis, Insights and Forecast - By Technology
  • 5.2.1. Time Domain OCT (TD-OCT)
  • 5.2.2. Spectral Domain OCT (SD-OCT)
  • 5.2.3. Swept Source OCT (SS-OCT)
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Ophthalmology
  • 5.3.2. Cardiology
  • 5.3.3. Oncology
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Hospitals & ASCs
  • 5.4.2. Specialty Clinics
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Optical Coherence Tomography Market Analysis, Insights and Forecast, 2019-2032

• 6.1. Market Analysis, Insights and Forecast - By Device Type
  • 6.1.1. Tabletop
  • 6.1.2. Portable and Handheld
• 6.2. Market Analysis, Insights and Forecast - By Technology
  • 6.2.1. Time Domain OCT (TD-OCT)
  • 6.2.2. Spectral Domain OCT (SD-OCT)
  • 6.2.3. Swept Source OCT (SS-OCT)
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Ophthalmology
  • 6.3.2. Cardiology
  • 6.3.3. Oncology
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Hospitals & ASCs
  • 6.4.2. Specialty Clinics
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Optical Coherence Tomography Market Analysis, Insights and Forecast, 2019-2032

• 7.1. Market Analysis, Insights and Forecast - By Device Type
  • 7.1.1. Tabletop
  • 7.1.2. Portable and Handheld
• 7.2. Market Analysis, Insights and Forecast - By Technology
  • 7.2.1. Time Domain OCT (TD-OCT)
  • 7.2.2. Spectral Domain OCT (SD-OCT)
  • 7.2.3. Swept Source OCT (SS-OCT)
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Ophthalmology
  • 7.3.2. Cardiology
  • 7.3.3. Oncology
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Hospitals & ASCs
  • 7.4.2. Specialty Clinics
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.5.1. Germany
  • 7.5.2. U.K.
  • 7.5.3. France
  • 7.5.4. Italy
  • 7.5.5. Spain
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Optical Coherence Tomography Market Analysis, Insights and Forecast, 2019-2032

• 8.1. Market Analysis, Insights and Forecast - By Device Type
  • 8.1.1. Tabletop
  • 8.1.2. Portable and Handheld
• 8.2. Market Analysis, Insights and Forecast - By Technology
  • 8.2.1. Time Domain OCT (TD-OCT)
  • 8.2.2. Spectral Domain OCT (SD-OCT)
  • 8.2.3. Swept Source OCT (SS-OCT)
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Ophthalmology
  • 8.3.2. Cardiology
  • 8.3.3. Oncology
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Hospitals & ASCs
  • 8.4.2. Specialty Clinics
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.5.1. China
  • 8.5.2. India
  • 8.5.3. Japan
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Optical Coherence Tomography Market Analysis, Insights and Forecast, 2019-2032

• 9.1. Market Analysis, Insights and Forecast - By Device Type
  • 9.1.1. Tabletop
  • 9.1.2. Portable and Handheld
• 9.2. Market Analysis, Insights and Forecast - By Technology
  • 9.2.1. Time Domain OCT (TD-OCT)
  • 9.2.2. Spectral Domain OCT (SD-OCT)
  • 9.2.3. Swept Source OCT (SS-OCT)
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Ophthalmology
  • 9.3.2. Cardiology
  • 9.3.3. Oncology
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Hospitals & ASCs
  • 9.4.2. Specialty Clinics
  • 9.4.3. Others
• 9.5. and Forecast - By Country/ Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Optical Coherence Tomography Market Analysis, Insights and Forecast, 2019-2032

• 10.1. Market Analysis, Insights and Forecast - By Device Type
  • 10.1.1. Tabletop
  • 10.1.2. Portable and Handheld
• 10.2. Market Analysis, Insights and Forecast - By Technology
  • 10.2.1. Time Domain OCT (TD-OCT)
  • 10.2.2. Spectral Domain OCT (SD-OCT)
  • 10.2.3. Swept Source OCT (SS-OCT)
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Ophthalmology
  • 10.3.2. Cardiology
  • 10.3.3. Oncology
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Hospitals & ASCs
  • 10.4.2. Specialty Clinics
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.5.1. South Africa
  • 10.5.2. GCC
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2024)
• 11.2. Company Profiles
  • 11.2.1. ZEISS Group
    • 11.2.1.1. Overview
    • 11.2.1.2. Services
    • 11.2.1.3. Financials (Based on Availability)
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. SWOT,Etc.
  • 11.2.2. Heidelberg Engineering Inc.
    • 11.2.2.1. Overview
    • 11.2.2.2. Services
    • 11.2.2.3. Financials (Based on Availability)
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. SWOT,Etc.
  • 11.2.3. VivoSight
    • 11.2.3.1. Overview
    • 11.2.3.2. Services
    • 11.2.3.3. Financials (Based on Availability)
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. SWOT,Etc.
  • 11.2.4. Novacam Technologies, Inc.
    • 11.2.4.1. Overview
    • 11.2.4.2. Services
    • 11.2.4.3. Financials (Based on Availability)
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. SWOT,Etc.
  • 11.2.5. Leica Microsystems
    • 11.2.5.1. Overview
    • 11.2.5.2. Services
    • 11.2.5.3. Financials (Based on Availability)
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. SWOT,Etc.
  • 11.2.6. Abbott
    • 11.2.6.1. Overview
    • 11.2.6.2. Services
    • 11.2.6.3. Financials (Based on Availability)
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. SWOT,Etc.
  • 11.2.7. Topcon Corporation
    • 11.2.7.1. Overview
    • 11.2.7.2. Services
    • 11.2.7.3. Financials (Based on Availability)
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. SWOT,Etc.
  • 11.2.8. Terumo Corporation
    • 11.2.8.1. Overview
    • 11.2.8.2. Services
    • 11.2.8.3. Financials (Based on Availability)
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. SWOT,Etc.
  • 11.2.9. Thorlabs, Inc.
    • 11.2.9.1. Overview
    • 11.2.9.2. Services
    • 11.2.9.3. Financials (Based on Availability)
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. SWOT,Etc.
  • 11.2.10. PHILOPHOS
    • 11.2.10.1. Overview
    • 11.2.10.2. Services
    • 11.2.10.3. Financials (Based on Availability)
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. SWOT,Etc.
  • 11.2.11. NIDEK CO., LTD.
    • 11.2.11.1. Overview
    • 11.2.11.2. Services
    • 11.2.11.3. Financials (Based on Availability)
    • 11.2.11.4. Recent Developments
    • 11.2.11.5. Strategies
    • 11.2.11.6. SWOT,Etc.